[1] O′REILLY M S， BOEHM T，SHING Y，et al. Endostatin：an endogenous inhibitor of angiogenesis and tumor growth[J] .Cell，1997，88(2)：277-285. [2] HELJASVAARA R，NYBERG P，LUOSTARINEN J，et al. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases[J] .Exp Cell Res，2005，307(2)：292-304. [3] FELBOR U，DREIER L，BRYANT R A，et al. Secreted cathepsin L generates endostatin from collagen ⅩⅧ[J] .EMBO J，2000，19(6)：1187-1194. [4] WU J X，FU W Z，LUO J X，et al. Expression and purification of human endostatin from Hansenula polymorpha A16[J] . Protein Expr Purif，2005，42：12-19. [5] YAMAGUCHI N，ANAND-APTE B，LEE M，et al. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding[J] .EMBO J，1999，18(16)：4414-4423. [6] BOEHM T，O′REILLY M S，KEOUGH K，et al. Zinc binding of endostatini essential for its antiangio-collagen ⅩⅧ/ endostatin control of angiogenesis genic activity [J] .Biochem Biophys Res Commun，1998，252(1)：190-194. [7] KIM Y M，HWANG S，KIM Y M，et al. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1[J] .J Biol Chem，2002，277(31)：27872-27879. [8] SUND M，HAMANO Y，SUGIMOTO H，et al. Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors[J] .Proc Natl Acad Sci USA，2005，102 (8)：2934-2939. [9] SUDHAKAR A，SUGIMOTO H，YANG C，et al.Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha vbeta3 and alpha 5beta 1 interins[J] .Proc Natl Acad Sci USA，2003，100(8)：4766-4771. [10] HELJASVAARA R，NYBERG P，LUOSTARIN J，et al. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases[J] .Exp Cell Res，2005，307 (2)：292-304. [11] LI R F，WANG Z F，HUANG X L，et al. The effect of local injected endostatin on mice Lewis lung cancer[J] .J Prac Oncol(实用肿瘤学杂志)，2003，17(3)：164-167. [12] MA L Y，LI Q，LIU Z L. Combination of adenovirus-mediated endostatin gene and chemotherapy in treatment of Lewis lung cancer in mice [J] .Acad J Sec Mil Med Univ(第二军医大学学报)，2004，25(7)：725-728. [13] WU Y，YANG L，HU B，et al. Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine[J] .Anticancer Drugs，2005，16(5)：551-557. [14] YANG W，LI X Y. Anti-tumor effect of pEgr-interferon-gamma-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism[J] .Chin Med J (Engl)，2005，118(4)：296-301. [15] LING C H，JI C，CHEN Y B，et al. Combined effects of endostatin gene transfer and ionizing radiation on lung adenocarcinoma model of A5492 cells [J] . Chin J Tuberc Respir Dis(中华结核和呼吸杂志)，2004，27(10)：683-686. [16] LUO X，ANDRES M L，TIMIRYASOVA T M，et al. Radiation-enhanced endostatin gene expression and effects of combination treatment[J] . Technol Cancer Res Treat，2005，4 (2)：193-202. [17] WU G Q，FENG Y，ZHANG X F，et al. Serum endostatin levels in patients with primary hepatocellular carcinoma [J] . Chongqing Med J (重庆医学)，2004，33(12)：1843-1844. [18] UEMATSU S，HIGASHI T，NOUSO K，et al. Altered expression of vascular endothelial growth factor，fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma[J] . J Gastroenterol Hepatol，2005，20(4)：583-586. [19] TSUBOI S，NOUSO K，TOMONO Y，et al. Anti-endostatin monoclonal antibody enhances growth of human hepatocellular carcinoma cells by inhibiting activity of endostatin secreted by the transplanted cells in nude mice[J] . Int J Oncol，2004，25(5)：1267-1271. [20] FU G F，LI X，HOU Y Y，et al. Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer[J] . Cancer Gene Ther，2005，12(2)：133-140. [21] ZHENG A Q，SONG X R，YU J M，et al. Liposome transfected to plasmid-encoding endostatin gene combined with radiotherapy inhibits liver cancer growth in nude mice[J] . World J Gastroenterol，2005，11(28)：4439-4442. [22] WANG T B，WU X P，ZHANG W D，et al. The influences of recombinant human endostatin on the growth of gastric cancer in nude mice[J] .Chin J Gen Surg (中国普通外科杂志)，2004，14(2)：268-270. [23] CHANG W H，ZHAO Z G，ZHANG Y H，et al. Expression of endostatin and microvessel density in gastric carcinoma tissue[J] .J Zhengzhou Univ(郑州大学学报医学版)，2005， 40(3)：502-504. [24] TE VELDE E A，REIJERKERK A，BRANDSMA D，et al. Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells[J] . Br J Cancer，2005，92(4)：727-729. [25] YOKOYAMA Y，RAMAKRISHNAN S. Addition of integrin binding sequence to a mutant human endostatin improves inhibition of tumor growth[J] .Intl J Cancer，2004，111 (6)：839-848. [26] WIGMORE S J. Endostatin in the pancreas[J] .Br J Cancer，2005，92 (1)：5-6. [27] NORO T，MIYAKE K，SUZUKI-MIYAKE N，et al. Adeno-associated viral vector-mediated expression of endostatin inhibits tumor growth and metastasis in an orthotropic pancreatic cancer model in hamsters[J] .Cancer Res，2004，64 (20)：7486-7490. [28] LUO C Y，ZHAO D N，LIU Y L，et al. Treatment of colorectal carcinoma with endostatin gene transducted by cation liposome [J] .Chin J Exp Surg(中华实验外科杂志)，2004，21(7)：879-879. [29] YOKOYAMA Y，RAMAKRISHNAN S. Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth[J] .Cancer，2005，104 (2)：321-331. [30] VAN ISAYEVA T，REN C，PONNAZHAGAN S. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer[J] .Clin Cancer Res，2005，11 (3)：1342-1347. [31] SUBRAMANIAN I V，GHEBRE R，RAMAKRISHNAN S. Adeno-associated virus-mediated delivery of a mutant endostatin suppresses ovarian carcinoma growth in mice[J] .Gene Ther，2005，12(1)：30-38. [32] VAN WIJNGAARDEN J，DE R K，VAN BEEK E，et al. Identification of differentially expressed genes in a renal cell carcinoma tumor model after endostatin treatment[J] .Lab Invest，2004，84 (11)：1472-1483. [33] CHO H M，ROSENBLATT J D，KANG Y S，et al. Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein[J] .Mol Cancer Ther，2005，4 (6)：956-967.